In the last 12 months, insiders at Jaguar Health, Inc. ($JAGX) filed 136 transactions with the SEC: 17 open-market purchases totaling $420,010 and 0 sales totaling $0. Net insider sentiment: net buying.
Jaguar Health, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- BOCHNOWSKI JAMES J (Not found) — 8 transactions totaling $450,000
- CONTE LISA A (CEO and President) — 16 transactions totaling $150,000
- MICEK JOHN (Not found) — 8 transactions totaling $150,000
- Siegel Jonathan B. (Not found) — 8 transactions totaling $150,000
- Wolin Jonathan S. (See Remarks) — 9 transactions totaling $150,000
View all SEC Filings for Jaguar Health, Inc. (JAGX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 11, 2025 | MICEK JOHN | Not found | A | Stock Option (right to buy) | 7377 | $0.00 | 7,377.0000 | 3,735,837 | 9999.99% | 0.20% |
| Dec. 11, 2025 | MICEK JOHN | Not found | A | Common Stock | 7377 | $0.00 | 7,430.0000 | 3,735,837 | 9999.99% | 0.20% |
| Dec. 11, 2025 | King Steven R. | See Remarks | A | Stock Option (right to buy) | 11740 | $0.00 | 11,740.0000 | 3,735,837 | 9999.99% | 0.31% |
| Dec. 11, 2025 | Wolin Jonathan S. | See Remarks | A | Common Stock | 11740 | $0.00 | 11,938.0000 | 3,735,837 | 5929.29% | 0.31% |
| Dec. 11, 2025 | Wolin Jonathan S. | See Remarks | A | Stock Option (right to buy) | 11740 | $0.00 | 11,740.0000 | 3,735,837 | 9999.99% | 0.31% |
| Dec. 11, 2025 | CONTE LISA A | See Remarks | A | Common Stock | 28592 | $0.00 | 29,258.0000 | 3,735,837 | 4293.09% | 0.77% |
| Dec. 11, 2025 | CONTE LISA A | See Remarks | A | Stock Option (right to buy) | 28592 | $0.00 | 28,592.0000 | 3,735,837 | 9999.99% | 0.77% |
| Dec. 11, 2025 | King Steven R. | See Remarks | A | Common Stock | 11740 | $0.00 | 11,885.0000 | 3,735,837 | 8096.55% | 0.31% |
| Dec. 11, 2025 | Chaturvedi Pravin R | Chief Scientific Officer | A | Common Stock | 11740 | $0.00 | 11,938.0000 | 3,735,837 | 5929.29% | 0.31% |
| Dec. 11, 2025 | Lizak Carol R. | Chief Financial Officer | A | Common Stock | 11740 | $0.00 | 11,911.0000 | 3,735,837 | 6865.50% | 0.31% |
| Dec. 11, 2025 | Lizak Carol R. | Chief Financial Officer | A | Stock Option (right to buy) | 11740 | $0.00 | 11,740.0000 | 3,735,837 | 9999.99% | 0.31% |
| Dec. 11, 2025 | Jayasuriya Anula | Not found | A | Common Stock | 5870 | $0.00 | 5,916.0000 | 3,735,837 | 9999.99% | 0.16% |
| Dec. 11, 2025 | Jayasuriya Anula | Not found | A | Stock Option (right to buy) | 5870 | $0.00 | 5,870.0000 | 3,735,837 | 9999.99% | 0.16% |
| Dec. 11, 2025 | Siegel Jonathan B. | Not found | A | Stock Option (right to buy) | 7377 | $0.00 | 7,377.0000 | 3,735,837 | 9999.99% | 0.20% |
| Dec. 11, 2025 | Siegel Jonathan B. | Not found | A | Common Stock | 7377 | $0.00 | 7,423.0000 | 3,735,837 | 9999.99% | 0.20% |
| Dec. 11, 2025 | BOCHNOWSKI JAMES J | Not found | A | Stock Option (right to buy) | 6363 | $0.00 | 6,363.0000 | 3,735,837 | 9999.99% | 0.17% |
| Dec. 11, 2025 | BOCHNOWSKI JAMES J | Not found | A | Common Stock | 6363 | $0.00 | 6,415.0000 | 3,735,837 | 9999.99% | 0.17% |
| Dec. 11, 2025 | Chaturvedi Pravin R | Chief Scientific Officer | A | Stock Option (right to buy) | 11740 | $0.00 | 11,740.0000 | 3,735,837 | 9999.99% | 0.31% |
| June 24, 2025 | CONTE LISA A | CEO and President | A | Warrant to Purchase Common Stock | 18262 | $0.00 | 9,000.0000 | 674,043 | 0.00% | 2.71% |
| June 24, 2025 | King Steven R. | See Remarks | A | Convertible Promissory Note | 3785 | $20.00 | 3,785.0000 | 674,043 | 9999.99% | 0.56% |
| June 24, 2025 | King Steven R. | See Remarks | A | Warrant to Purchase Common Stock | 7304 | $0.00 | 3,600.0000 | 674,043 | 0.00% | 1.08% |
| June 24, 2025 | Chaturvedi Pravin R | Chief Scientific Officer | D | Convertible Promissory Note | 3600 | $20000.00 | 0.0000 | 674,043 | 100.00% | 0.53% |
| June 24, 2025 | Chaturvedi Pravin R | Chief Scientific Officer | A | Convertible Promissory Note | 3785 | $20000.00 | 3,785.0000 | 674,043 | 9999.99% | 0.56% |
| June 24, 2025 | Chaturvedi Pravin R | Chief Scientific Officer | A | Warrant to Purchase Common Stock | 7304 | $0.00 | 3,600.0000 | 674,043 | 0.00% | 1.08% |
| June 24, 2025 | Wolin Jonathan S. | See Remarks | D | Convertible Promissory Note | 9000 | $50000.00 | 0.0000 | 674,043 | 100.00% | 1.34% |
| June 24, 2025 | Wolin Jonathan S. | See Remarks | A | Convertible Promissory Note | 9462 | $50000.00 | 9,462.0000 | 674,043 | 9999.99% | 1.40% |
| June 24, 2025 | Wolin Jonathan S. | See Remarks | A | Warrant to Purchase Common Stock | 18262 | $0.00 | 9,000.0000 | 674,043 | 0.00% | 2.71% |
| June 24, 2025 | CONTE LISA A | CEO and President | D | Convertible Promissory Note | 9000 | $50000.00 | 0.0000 | 674,043 | 100.00% | 1.34% |
| June 24, 2025 | CONTE LISA A | CEO and President | A | Convertible Promissory Note | 9462 | $50000.00 | 9,462.0000 | 674,043 | 9999.99% | 1.40% |
| June 24, 2025 | Siegel Jonathan B. | Not found | A | Convertible Promissory Note | 9462 | $50000.00 | 9,462.0000 | 674,043 | 9999.99% | 1.40% |
| June 24, 2025 | Siegel Jonathan B. | Not found | A | Warrant to Purchase Common Stock | 18262 | $0.00 | 9,000.0000 | 674,043 | 0.00% | 2.71% |
| June 24, 2025 | MICEK JOHN | Not found | D | Convertible Promissory Note | 9000 | $50000.00 | 0.0000 | 674,043 | 100.00% | 1.34% |
| June 24, 2025 | Siegel Jonathan B. | Not found | D | Convertible Promissory Note | 9000 | $50000.00 | 0.0000 | 674,043 | 100.00% | 1.34% |
| June 24, 2025 | MICEK JOHN | Not found | A | Convertible Promissory Note | 9462 | $50000.00 | 9,462.0000 | 674,043 | 9999.99% | 1.40% |
| June 24, 2025 | MICEK JOHN | Not found | A | Warrant to Purchase Common Stock | 18262 | $0.00 | 9,000.0000 | 674,043 | 0.00% | 2.71% |
| June 24, 2025 | BOCHNOWSKI JAMES J | Not found | D | Convertible Promissory Note | 27002 | $150000.00 | 0.0000 | 674,043 | 100.00% | 4.01% |
| June 24, 2025 | BOCHNOWSKI JAMES J | Not found | A | Convertible Promissory Note | 28388 | $150000.00 | 28,388.0000 | 674,043 | 9999.99% | 4.21% |
| June 24, 2025 | BOCHNOWSKI JAMES J | Not found | A | Warrant to Purchase Common Stock | 54786 | $0.00 | 27,002.0000 | 674,043 | 0.00% | 8.13% |
| June 24, 2025 | King Steven R. | See Remarks | D | Convertible Promissory Note | 3600 | $20000.00 | 0.0000 | 674,043 | 100.00% | 0.53% |
| May 17, 2025 | CONTE LISA A | CEO and President | M | Restricted stock units | 2 | $0.00 | 0.0000 | 674,043 | 100.00% | 0.00% |
| May 17, 2025 | CONTE LISA A | CEO and President | M | Common Stock | 2 | $0.00 | 666.0000 | 674,043 | 0.30% | 0.00% |
| May 17, 2025 | King Steven R. | See Remarks | M | Restricted stock units | 1 | $0.00 | 0.0000 | 674,043 | 100.00% | 0.00% |
| May 17, 2025 | King Steven R. | See Remarks | M | Common Stock | 1 | $0.00 | 145.0000 | 674,043 | 0.69% | 0.00% |
| March 31, 2025 | Siegel Jonathan B. | Not found | P | Warrant to Purchase Common Stock | 9000 | $0.00 | 9,000.0000 | 0 | 9999.99% | 0.00% |
| March 31, 2025 | Siegel Jonathan B. | Not found | P | Convertible Promissory Note | 9000 | $50000.00 | 9,000.0000 | 0 | 9999.99% | 0.00% |
| March 31, 2025 | King Steven R. | See Remarks | P | Warrant to Purchase Common Stock | 3600 | $0.00 | 3,600.0000 | 0 | 9999.99% | 0.00% |
| March 31, 2025 | King Steven R. | See Remarks | P | Convertible Promissory Note | 3600 | $20000.00 | 3,600.0000 | 0 | 9999.99% | 0.00% |
| March 31, 2025 | MICEK JOHN | Not found | P | Warrant to Purchase Common Stock | 9000 | $0.00 | 9,000.0000 | 0 | 9999.99% | 0.00% |
| March 31, 2025 | MICEK JOHN | Not found | P | Convertible Promissory Note | 9000 | $50000.00 | 9,000.0000 | 0 | 9999.99% | 0.00% |
| March 31, 2025 | Lizak Carol R. | Chief Financial Officer | P | Convertible Promissory Note | 5400 | $30000.00 | 5,400.0000 | 0 | 9999.99% | 0.00% |
| March 31, 2025 | Lizak Carol R. | Chief Financial Officer | P | Warrant to Purchase Common Stock | 5400 | $0.00 | 5,400.0000 | 0 | 9999.99% | 0.00% |
| March 31, 2025 | BOCHNOWSKI JAMES J | Not found | P | Warrant to Purchase Common Stock | 27002 | $0.00 | 27,002.0000 | 0 | 9999.99% | 0.00% |
| March 31, 2025 | BOCHNOWSKI JAMES J | Not found | P | Convertible Promissory Note | 27002 | $150000.00 | 27,002.0000 | 0 | 9999.99% | 0.00% |
| March 31, 2025 | Wolin Jonathan S. | See Remarks | P | Warrant to Purchase Common Stock | 9000 | $0.00 | 9,000.0000 | 0 | 9999.99% | 0.00% |
| March 31, 2025 | Chaturvedi Pravin R | Chief Scientific Officer | P | Warrant to Purchase Common Stock | 3600 | $0.00 | 3,600.0000 | 0 | 9999.99% | 0.00% |
| March 31, 2025 | Wolin Jonathan S. | See Remarks | P | Convertible Promissory Note | 9000 | $50000.00 | 9,000.0000 | 0 | 9999.99% | 0.00% |
| March 31, 2025 | Chaturvedi Pravin R | Chief Scientific Officer | P | Convertible Promissory Note | 3600 | $20000.00 | 3,600.0000 | 0 | 9999.99% | 0.00% |
| March 31, 2025 | CONTE LISA A | CEO and President | P | Warrant to Purchase Common Stock | 9000 | $0.00 | 9,000.0000 | 0 | 9999.99% | 0.00% |
| March 31, 2025 | CONTE LISA A | CEO and President | P | Convertible Promissory Note | 9000 | $50000.00 | 9,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 8, 2024 | MICEK JOHN | Not found | A | Stock option (right to buy) | 26500 | $0.00 | 26,500.0000 | 0 | 9999.99% | 0.00% |
| Oct. 8, 2024 | Lizak Carol R. | Chief Financial Officer | A | Common Stock | 4280 | $0.00 | 4,298.0000 | 0 | 9999.99% | 0.00% |
| Oct. 8, 2024 | Lizak Carol R. | Chief Financial Officer | A | Stock option (right to buy) | 34240 | $0.00 | 34,240.0000 | 0 | 9999.99% | 0.00% |
| Oct. 8, 2024 | Chaturvedi Pravin R | Chief Scientific Officer | A | Common Stock | 4922 | $0.00 | 4,957.0000 | 0 | 9999.99% | 0.00% |
| Oct. 8, 2024 | Chaturvedi Pravin R | Chief Scientific Officer | A | Stock option (right to buy) | 39376 | $0.00 | 39,376.0000 | 0 | 9999.99% | 0.00% |
| Oct. 8, 2024 | Wolin Jonathan S. | See Remarks | A | Common Stock | 4922 | $0.00 | 4,955.0000 | 0 | 9999.99% | 0.00% |
| Oct. 8, 2024 | Wolin Jonathan S. | See Remarks | A | Stock option (right to buy) | 39376 | $0.00 | 39,376.0000 | 0 | 9999.99% | 0.00% |
| Oct. 8, 2024 | CONTE LISA A | See Remarks | A | Common Stock | 16503 | $0.00 | 16,624.0000 | 0 | 9999.99% | 0.00% |
| Oct. 8, 2024 | CONTE LISA A | See Remarks | A | Stock option (right to buy) | 132020 | $0.00 | 132,020.0000 | 0 | 9999.99% | 0.00% |
| Oct. 8, 2024 | BOCHNOWSKI JAMES J | Not found | A | Stock option (right to buy) | 23200 | $0.00 | 23,200.0000 | 0 | 9999.99% | 0.00% |
| Oct. 8, 2024 | Jayasuriya Anula | Not found | A | Stock option (right to buy) | 21000 | $0.00 | 21,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 8, 2024 | King Steven R. | See Remarks | A | Common Stock | 4922 | $0.00 | 4,951.0000 | 0 | 9999.99% | 0.00% |
| Oct. 8, 2024 | King Steven R. | See Remarks | A | Stock option (right to buy) | 39376 | $0.00 | 39,376.0000 | 0 | 9999.99% | 0.00% |
| Oct. 8, 2024 | Siegel Jonathan B. | Not found | A | Stock option (right to buy) | 26500 | $0.00 | 26,500.0000 | 0 | 9999.99% | 0.00% |
| May 17, 2024 | CONTE LISA A | CEO and President | M | Restricted stock units | 2695 | $0.00 | 2,694.0000 | 0 | 50.01% | 0.00% |
| May 17, 2024 | CONTE LISA A | CEO and President | M | Common Stock | 2695 | $0.00 | 7,295.0000 | 0 | 58.59% | 0.00% |
| May 17, 2024 | King Steven R. | See Remarks | M | Restricted stock units | 612 | $0.00 | 612.0000 | 0 | 50.00% | 0.00% |
| May 17, 2024 | King Steven R. | See Remarks | M | Common Stock | 612 | $0.00 | 1,756.0000 | 0 | 53.50% | 0.00% |
| May 17, 2024 | Lizak Carol R. | Chief Financial Officer | M | Restricted stock units | 431 | $0.00 | 431.0000 | 0 | 50.00% | 0.00% |
| May 17, 2024 | Lizak Carol R. | Chief Financial Officer | M | Common Stock | 431 | $0.00 | 1,148.0000 | 0 | 60.11% | 0.00% |
| May 17, 2024 | Wolin Jonathan S. | Chief of Staff, CCO & GC | M | Restricted stock units | 871 | $0.00 | 871.0000 | 0 | 50.00% | 0.00% |
| May 17, 2024 | Wolin Jonathan S. | Chief of Staff, CCO & GC | M | Common Stock | 871 | $0.00 | 2,012.0000 | 0 | 76.34% | 0.00% |
| May 17, 2024 | Chaturvedi Pravin R | Chief Scientific Officer | M | Restricted stock units | 871 | $0.00 | 871.0000 | 0 | 50.00% | 0.00% |
| May 17, 2024 | Chaturvedi Pravin R | Chief Scientific Officer | M | Common Stock | 871 | $0.00 | 2,141.0000 | 0 | 68.58% | 0.00% |
| April 5, 2024 | Wolin Jonathan S. | Chief of Staff, CCO & GC | A | Restricted stock units | 89 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 5, 2024 | Chaturvedi Pravin R | Chief Scientific Officer | M | Common Stock | 134 | $0.00 | 1,270.0000 | 0 | 11.80% | 0.00% |
| April 5, 2024 | Chaturvedi Pravin R | Chief Scientific Officer | A | Restricted stock units | 134 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 5, 2024 | Wolin Jonathan S. | Chief of Staff, CCO & GC | M | Common Stock | 89 | $0.00 | 1,141.0000 | 0 | 8.46% | 0.00% |
| April 5, 2024 | Lizak Carol R. | Chief Financial Officer | M | Common Stock | 60 | $0.00 | 717.0000 | 0 | 9.13% | 0.00% |
| April 5, 2024 | Lizak Carol R. | Chief Financial Officer | A | Restricted stock units | 60 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 5, 2024 | King Steven R. | See Remarks | M | Common Stock | 178 | $0.00 | 1,144.0000 | 0 | 18.43% | 0.00% |
| April 5, 2024 | King Steven R. | See Remarks | A | Restricted stock units | 178 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 5, 2024 | CONTE LISA A | CEO and President | M | Common Stock | 600 | $0.00 | 4,600.0000 | 0 | 15.00% | 0.00% |
| April 5, 2024 | CONTE LISA A | CEO and President | A | Restricted stock units | 600 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 14, 2023 | Wolin Jonathan S. | Chief of Staff, CCO & GC | A | Common Stock | 196628 | $0.00 | 197,680.0000 | 0 | 9999.99% | 0.00% |
| Aug. 14, 2023 | Lizak Carol R. | Chief Financial Officer | A | Common Stock | 142088 | $0.00 | 150,713.0000 | 0 | 1647.40% | 0.00% |
| Aug. 14, 2023 | King Steven R. | see remarks | A | Common Stock | 159168 | $0.00 | 160,133.0000 | 0 | 9999.99% | 0.00% |
| July 1, 2023 | Jayasuriya Anula | Director | A | Common Stock | 1718 | $0.00 | 1,718.0000 | 0 | 9999.99% | 0.00% |
| Aug. 14, 2023 | Jayasuriya Anula | Director | A | Common Stock | 68568 | $0.00 | 70,286.0000 | 0 | 3991.15% | 0.00% |
| July 1, 2023 | Jayasuriya Anula | Director | A | Restricted stock units | 1718 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 14, 2023 | Siegel Jonathan B. | Director | A | Common Stock | 68568 | $0.00 | 69,933.0000 | 0 | 5023.30% | 0.00% |
| Aug. 14, 2023 | MICEK JOHN | Director | A | Common Stock | 68568 | $0.00 | 80,701.0000 | 0 | 565.14% | 0.00% |
| Aug. 14, 2023 | BOCHNOWSKI JAMES J | Director | A | Common Stock | 76613 | $0.00 | 78,876.0000 | 0 | 3385.46% | 0.00% |
| Aug. 14, 2023 | Chaturvedi Pravin R | Chief Scientific Officer | A | Common Stock | 204192 | $0.00 | 205,328.0000 | 0 | 9999.99% | 0.00% |
| Aug. 14, 2023 | CONTE LISA A | CEO and President | A | Common Stock | 383605 | $0.00 | 387,605.0000 | 0 | 9590.13% | 0.00% |
| May 17, 2023 | MICEK JOHN | Director | M | Common Stock | 1145 | $0.00 | 1,306.0000 | 0 | 711.18% | 0.00% |
| May 17, 2023 | Siegel Jonathan B. | Director | M | Restricted stock units | 1145 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 17, 2023 | Siegel Jonathan B. | Director | M | Common Stock | 1145 | $0.00 | 1,365.0000 | 0 | 520.45% | 0.00% |
| May 17, 2023 | Chaturvedi Pravin R | Chief Scientific Officer | M | Restricted stock units | 870 | $0.00 | 1,742.0000 | 0 | 33.31% | 0.00% |
| May 17, 2023 | Chaturvedi Pravin R | Chief Scientific Officer | M | Common Stock | 870 | $0.00 | 1,136.0000 | 0 | 327.07% | 0.00% |
| April 5, 2023 | Chaturvedi Pravin R | Chief Scientific Officer | M | Common Stock | 133 | $0.00 | 266.0000 | 0 | 100.00% | 0.00% |
| May 17, 2023 | Wolin Jonathan S. | Chief of Staff, CCO & GC | M | Common Stock | 871 | $0.00 | 1,052.0000 | 0 | 481.22% | 0.00% |
| May 17, 2023 | Wolin Jonathan S. | Chief of Staff, CCO & GC | M | Restricted stock units | 871 | $0.00 | 1,742.0000 | 0 | 33.33% | 0.00% |
| May 17, 2023 | Lizak Carol R. | Chief Financial Officer | M | Common Stock | 431 | $0.00 | 8,625.0000 | 0 | 5.26% | 0.00% |
| May 17, 2023 | Lizak Carol R. | Chief Financial Officer | M | Restricted stock units | 431 | $0.00 | 862.0000 | 0 | 33.33% | 0.00% |
| May 17, 2023 | King Steven R. | Chief of Sustainable Supply | M | Common Stock | 611 | $0.00 | 965.0000 | 0 | 172.60% | 0.00% |
| May 17, 2023 | King Steven R. | Chief of Sustainable Supply | M | Restricted stock units | 611 | $0.00 | 1,224.0000 | 0 | 33.30% | 0.00% |
| May 17, 2023 | CONTE LISA A | CEO and President | M | Common Stock | 2694 | $0.00 | 4,000.0000 | 0 | 206.28% | 0.00% |
| May 17, 2023 | CONTE LISA A | CEO and President | M | Restricted stock units | 2694 | $0.00 | 5,389.0000 | 0 | 33.33% | 0.00% |
| May 17, 2023 | BOCHNOWSKI JAMES J | Director | M | Common Stock | 1280 | $0.00 | 2,263.0000 | 0 | 130.21% | 0.00% |
| May 17, 2023 | MICEK JOHN | Director | M | Restricted stock units | 1145 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 17, 2023 | BOCHNOWSKI JAMES J | Director | M | Restricted stock units | 1280 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 5, 2023 | Chaturvedi Pravin R | Chief Scientific Officer | A | Restricted stock units | 133 | $0.00 | 134.0000 | 0 | 9999.99% | 0.00% |
| April 5, 2022 | Chaturvedi Pravin R | Chief Scientific Officer | M | Common Stock | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| April 5, 2022 | Chaturvedi Pravin R | Chief Scientific Officer | A | Restricted stock units | 10000 | $0.00 | 20,000.0000 | 0 | 100.00% | 0.00% |
| April 5, 2023 | CONTE LISA A | CEO and President | M | Common Stock | 600 | $0.00 | 1,306.0000 | 0 | 84.99% | 0.00% |
| April 5, 2023 | King Steven R. | Chief of Sustainable Supply | M | Common Stock | 177 | $0.00 | 354.0000 | 0 | 100.00% | 0.00% |
| April 5, 2023 | Wolin Jonathan S. | Chief of Staff, CCO & GC | A | Restricted stock units | 88 | $0.00 | 88.0000 | 0 | 9999.99% | 0.00% |
| April 5, 2023 | Wolin Jonathan S. | Chief of Staff, CCO & GC | M | Common Stock | 88 | $0.00 | 181.0000 | 0 | 94.62% | 0.00% |
| April 5, 2023 | Lizak Carol R. | Chief Financial Officer | A | Restricted stock units | 60 | $0.00 | 60.0000 | 0 | 9999.99% | 0.00% |
| April 5, 2023 | Lizak Carol R. | Chief Financial Officer | M | Common Stock | 60 | $0.00 | 226.0000 | 0 | 36.14% | 0.00% |
| April 5, 2023 | Chaturvedi Pravin R | Chief Scientific Officer | M | Common Stock | 44 | $0.00 | 88.0000 | 0 | 100.00% | 0.00% |
| April 5, 2023 | Chaturvedi Pravin R | Chief Scientific Officer | A | Restricted stock units | 44 | $0.00 | 44.0000 | 0 | 9999.99% | 0.00% |
| April 5, 2023 | CONTE LISA A | CEO and President | A | Restricted stock units | 600 | $0.00 | 600.0000 | 0 | 9999.99% | 0.00% |
| April 5, 2023 | King Steven R. | Chief of Sustainable Supply | A | Restricted stock units | 177 | $0.00 | 177.0000 | 0 | 9999.99% | 0.00% |
| April 6, 2023 | Jayasuriya Anula | Director | A | Restricted stock units | 1718 | $0.00 | 1,718.0000 | 0 | 50.00% | 0.00% |
| Dec. 31, 2022 | Wolin Jonathan S. | Chief of Staff, CCO & GC | P | Common Stock | 317 | $0.03 | 6,983.0000 | 0 | 4.76% | 0.00% |